Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality

Abstract

Tityus serrulatus sting causes thousands of deaths annually worldwide. T. serrulatus-envenomed victims exhibit local or systemic reaction that culminates in pulmonary oedema, potentially leading to death. However, the molecular mechanisms underlying T. serrulatus venom (TsV) activity remain unknown. Here we show that TsV triggers NLRP3 inflammasome activation via K+ efflux. Mechanistically, TsV triggers lung-resident cells to release PGE2, which induces IL-1β production via E prostanoid receptor 2/4-cAMP-PKA-NFκB-dependent mechanisms. IL-1β/IL-1R actions account for oedema and neutrophil recruitment to the lungs, leading to TsV-induced mortality. Inflammasome activation triggers LTB4 production and further PGE2 via IL-1β/IL-1R signalling. Activation of LTB4-BLT1/2 pathway decreases cAMP generation, controlling TsV-induced inflammation. Exogenous administration confirms LTB4 anti-inflammatory activity and abrogates TsV-induced mortality. These results suggest that the balance between LTB4 and PGE2 determines the amount of IL-1β inflammasome-dependent release and the outcome of envenomation. We suggest COX1/2 inhibition as an effective therapeutic intervention for scorpion envenomation.

Virus-induced inflammasome activation is suppressed by prostaglandin D 2 /DP1 signaling

“…On the other hand, eicosanoids also may regulate inflammasome activation, but the relationship is complex. Specifically, PGE 2 and PGJ 2 signaling either inhibit or enhance inflammasome activation, depending on the experimental system under study (3)(4)(5)(6)(7). PGD 2 /DP1 signaling may be especially important in inflammasome control in the virus-infected brain, but it should be noted that the balance between PGD 2 /DP1 signaling and inflammasome function must be finely tuned.…”

“…In one instance, inflammasome activation by flagellin resulted in eicosanoid dysregulation (an "eicosanoid storm") with hyperinflammatory responses and rapid lethality (1,2). Conversely, eicosanoids have been reported both to inhibit and to enhance inflammasome activation (3)(4)(5)(6)(7), although the precise mechanisms leading to each outcome are not well understood. Further, type I IFN (IFN-I), another key component of the innate immune response, also inhibits exuberant IL-1β expression (8,9).…”

Nonsteroidal Anti‐Inflammatory Therapy: A Journey Toward Safety

“…In 2010, NSAIDs were regularly used by about 30 million of US adults; from 1999 to 2012, around 15% of the Danish population was prescribed, at least once, nonaspirin NSAIDs; and almost 45% of the database population in France has acquired at least one NSAID during 2009–2010 . Furthermore, increasing evidences suggest that NSAIDs may be valuable for the prevention of cancer and neurodegenerative diseases and for the treatment of other inflammatory conditions, such as scorpion envenomation …”

Leukotriene B4licenses inflammasome activation to enhance skin host defense

“…Our data show that BLT1 activation is required for both in vivo and shown that PGE2/Eprostanoid receptor (EP) enhances PKA-dependent NLRP3 phosphorylation in macrophages. PGE2/PKA signaling is dictated by Gas-dependent cAMP production (3,51).…”